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Highlights 
 Highly polar and other anticoccidials can be separated on one analytical column.  
 SPE allows for the efficient isolation of 26 anticoccidials from water.  
 Validation has proven the method’s applicability to surface and groundwaters.  
 The method’s detection capability ranges from ppq (pg L-1) to ppt (ng L-1) levels.  
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Abstract 
A sensitive and selective method was developed and validated for the determination of 26 
anticoccidial compounds (six ionophores and twenty chemical coccidiostats) in surface and 
groundwater samples at parts-per-quadrillion (pg L
-1
) to parts-per-trillion (ng L
-1
) levels by 
ultra-high performance liquid chromatography with tandem mass spectrometry detection 
(UHPLC-MS/MS). A range of different analytical columns and mobile phase compositions 
were evaluated to enhance selectivity and retention of a number of highly polar and basic 
anticoccidials along with other non-polar coccidiostats. A combined separation, including 
these problematic polar compounds, was achieved on a phenyl-hexyl column, by binary 
gradient elution with water/acetonitrile using ammonium formate and formic acid as 
additives. The anticoccidial residues were extracted from raw, unfiltered, water samples (250 
mL) using polymeric divinylbenzene solid phase extraction (SPE) cartridges, with subsequent 
elution (methanol:acetonitrile:ethyl acetate, 40:40:20, v/v) and concentration prior to 
determination. The method recovery (at a concentration representative of realistic expected 
environmental water concentrations based on literature review) ranged from 81–105%. The 
method was successfully validated for 26 anticoccidials, at four concentration levels, in 
accordance to Commission Decision 2002/657/EC and SANTE/11813/2017 guidelines. 
Trueness and precision, under within-laboratory reproducibility conditions, ranged from 88–
111% and 0.9–10.3% respectively.  
 
Keywords: Chemical coccidiostats; Ionophores; Environmental water; SPE; UHPLC-
MS/MS. 
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1. Introduction  
Anticoccidials, interchangeably referred to as coccidiostats, are used to control coccidiosis 
and other protozoan infections in food producing animals [1, 2]. Coccidiosis is a parasitic 
intestinal disease caused by protozoa of the genus Eimeria. Anticoccidials can be classified 
into two main groups: the ionophores which are naturally occurring polyether antibiotic type 
compounds, and the synthetic/chemical anticoccidials [3]. Chemical anticoccidials are 
generally used at much lower concentrations compared to the ionophores, given that they 
have higher efficacy toward the parasites [4].  
 
Poultry have a high susceptibility to coccidiosis, which causes intestinal lesions and diarrhoea 
in the animal, resulting in poor weight gain and poor feed conversion. Due to the high 
number of birds housed at any one time, outbreak of infection poses huge economical loss. 
Very often, the damage to the bird occurs before it becomes symptomatic and hence, if 
infected, it is often difficult for the bird to recover, given their very short life cycle (approx. 
42 weeks) [5]. As a result, it is more financially viable to administer anticoccidials 
prophylactically as opposed to therapeutically, with broilers treated for a large portion of their 
life-cycle. 
 
In the European Union (EU), there are 11 anticoccidials licensed as feed additives under 
Regulations 1831/2003/EC [6], for use on intensively reared species, primarily poultry 
(broilers, turkeys, and layers), where the substance is administered in feed. These include the 
ionophores salinomycin, narasin, monensin, lasalocid, maduramicin and semduramicin, and 
the chemical anticoccidials robenidine, decoquinate, halofuginone, nicarbazin and diclazuril. 
In addition, some anticoccidials are authorised in the EU as veterinary medicines as listed 
under Commission Regulation No 37/2010 [7], which are used to a lesser extent in poultry, 
cattle, swine, sheep and rabbits. There are also a number of anticoccidials authorised for use 
outside of the EU, which include aklomide, arprinocid clopidol, diaveridine, ethopabate, 
nequinate and roxarsone [1, 4]. 
 
Of the information available, it has been reported that up to 95% of some anticoccidials can 
be excreted as the unmetabolised active parent drug e.g. diclazuril (85–95%) [9] and lasalocid 
(74–77%) [10]. This, combined with the prophylactic use, provides for a potentially 
persistent source of anticoccidials that can enter the environment, primarily via the spreading 
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of poultry manure and slurry [11]. Once in the environment, these compounds have the 
potential to: sorb and concentrate in soil, be washed to surface waters by overland flow, or be 
leached to groundwaters, depending on their mobility and fate, on which information is 
generally lacking. The main concern with anticoccidials in the environment relates to 
resistance issues caused by long term exposure to low levels, and potential eco-toxicological 
effects on aquatic and terrestrial organisms, given the antimicrobial potency of anticoccidials 
[4, 12, 13]. In a prioritisation exercise in the UK, Boxall et al. [14] classified 56 different 
veterinary drugs to be of “high priority” in terms of risk to the environment, based on (a) their 
potential to reach the environment in large amounts and (b) their hazard to aquatic and 
terrestrial organisms (based on available eco-toxicity data). Twelve different anticoccidial 
compounds were included in this high priority group.  
 
There has been a significant amount of work carried out on instrumental detection methods 
for anticoccidials, with the majority, and most extensive, of these methods relating to 
matrices of food of animal origin (e.g. poultry eggs, muscle, milk and liver) [1, 15, 16]. 
Clarke et al. [3] carried out a comprehensive overview of anticoccidial analysis in meat and 
other food products, providing a good overview of their history and advancements in their 
analysis and detection techniques. Based on this review, and published methods, liquid 
chromatography tandem mass spectrometry (LC-MS/MS) is currently considered the most 
powerful technique for determining anticoccidial residues in complex matrices. Instrumental 
detection is usually carried out using a reversed phase separation, with detection by tandem 
mass spectrometry using rapid polar switching electrospray ionisation (ESI). Notably, the 
Clarke et al. review highlights the complexity of analysis due to the broad range of 
physicochemical properties of anticoccidial compounds (e.g. highly polar amprolium and 
clopidol in contrast with some non-polar ionophores), with the authors emphasising the need 
to improve anticoccidial analysis to include these polar compounds. Since this review, some 
attempts have been made to incorporate highly polar compounds such as amprolium; 
however retention and peak shape still remained an issue based on the chromatograms 
presented [17]. 
 
In regard to environmental matrices, none of these comprehensive detection methods 
developed for food applications have been adapted and applied for environmental samples, 
with most methods for environmental samples incorporating no more than 12 anticoccidial 
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compounds, and very few methods incorporating both groups of anticoccidials [18, 19]. 
Amongst the methods available for environmental water samples, extraction and clean-up is 
generally performed by solid phase extraction (SPE), typically using reversed phase 
polymeric sorbents [20-26], eluted with methanol for subsequent evaporation and detection. 
The best overall method is considered to be that proposed by Herrero et al. [27] for the 
determination of five ionophores from river water and sewage treatment plant 
influent/effluent using Oasis HLB SPE cartridges with good recoveries and sensitivity 
achieved for river water.  
 
In a comprehensive review assessing analytical strategies for analysis in the environment, 
Hansen et al. [4] decided to report solely on ionophore compounds due to the scarcity of 
methods for the analysis of chemical anticoccidials in environmental samples. In concluding, 
the authors expressed an urgent need for development of robust, sensitive methods capable of 
monitoring both classes of anticoccidials in environmental matrices. Taking all of the above 
into consideration, the overall aim of this study was to firstly develop a more comprehensive 
chromatographic separation and detection method for the quantitative confirmatory 
determination of a larger suite of both ionophore and synthetic/chemical anticoccidials, 
particularly the highly polar and/or basic compounds, which to date have required separation 
on alternative column chemistries. This detection method would also include anticoccidials 
licensed outside the EU, to allow for a broader application in different geographical regions. 
The second focus of this study was to develop and optimise a sample clean-up procedure 
based on SPE, capable of extracting these anticoccidials from unfiltered raw samples, for 
particular application to surface and groundwaters. This extraction procedure would be more 
advantageous compared to previously reported methods as the analysis of unfiltered samples 
would avoid the loss of contaminants on filtering, which most methods to date have failed to 
consider, as was also highlighted by the Hansen et al. review. 
2. Experimental 
2.1 Chemicals, standards and consumables 
Ultra-pure water (UPW) (18.2 MΩcm) was generated in house using a Millipore water 
purification system (Cork, Ireland). The following super purity grade solvents (“SpS”) were 
purchased from Romil Ltd. (Cambridge, UK): acetonitrile (MeCN), ethyl acetate (EtOAc), 
methanol (MeOH) and propan-2-ol (IPA). Dimethyl sulfoxide (DMSO), ethylene glycol 
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(EG), 99.5% deuterated MeOH (MeOH-d), ammonium formate puriss p.a. (puriss pro 
analysis) and formic acid (HCOOH) (98-100%) were sourced from Sigma-Aldrich (Dublin, 
Ireland). Acetone puriss and ammonium acetate puriss p.a. (Fluka) (>98%) were purchased 
from Honeywell Research Chemicals (Honeywell Riedel-de Haen; Seelze, Germany). Acetic 
acid (CH3COOH) (100%) and ammonia solution (25% w/v) were obtained from Merck 
(Darmstadt, Germany). The ammonia solution was used to prepare 0.1 and 0.5M ammonium 
hydroxide (NH4OH) solutions for sample pH adjustment. Concentrated hydrochloric acid 
(HCl) (36%) was sourced from BDH Chemicals Ltd. (Poole, UK) and used to prepare a 0.1M 
HCl solution for pH adjustment.  
Neat analytical standards of aklomide (AKLO), amprolium hydrochloride (AMP), clopidol 
(CLOP), cyromazine (CYROM), decoquinate (DECO), diaveridine (DIAV), diclazuril 
(Diclaz), diminazene aceturate (DIMIN), dinitolmide (DINITOL), 4’,4’’-dinitrocarbanilide 
(DNC), ethopabate (ETHO), imidocarb dipropionate (IMIDO), maduramicin ammonium 
(MAD), monensin sodium salt hydrate (MON), nafamostat mesylate (NAFAM), narasin 
(NAR), nitromide (NITRO), pentamidine (PENT), piperazine (PIP) robenidine hydrochloride 
(ROB), roxarsone (ROX), salinomycin monosodium salt hydrate (SAL) and toltrazuril (TOL) 
were purchased from Sigma-Aldrich Ireland (Dublin, Ireland). Arprinocid (ARPRIN), 3-
Amino-2-methyl-5-nitrobenzamide (3-ANOT), buquinolate (BUQUIN), halofuginone 
hydrobromide (HALO-HBr), isometamidium chloride hydrochloride (ISOMET), nequinate 
(NEQUIN), toltrazuril sulphoxide (TOL-SO) and toltrazuril sulphone (TOL-SO2) were 
purchased from Witega (Berlin, Germany), as were the isotopically labelled internal 
standards: decoquinate-d5 (DECO-d5), dinitrocarbanilide-d8 (DNC-d8), ethopabate-d5 (ETHO-
d5), halofuginone hydrobromide-
13
C6 (HALO-HBr-
13
C6), imidocarb-d8 2HCl hydrate 
(IMIDO-d8) and robenidine hydrochloride-d8 (ROB-d8). The deuterated Cyromazine internal 
standard cyromazine-d4 (CYROM-d4) was purchased from C/D/N Isotopes Inc. (Quebec, 
Canada). Semduramicin sodium (SEMD) was obtained from the Community Reference 
Laboratory (CRL) (Berlin, Germany), while lasalocid A sodium (LAS) (Dr Ehrenstorfer 
GmbH, Augsburg, Germany) was sourced through LGC Standards (Middlesex, UK). 
 
Glass amber bottles, 1000 mL and 500 mL, were purchased from Sci Chem Scientific and 
Chemical Supplies Ltd. (Cork, Ireland). Glass wool (both silanised and unsilanised) was 
purchased Lennox Laboratory Supplies (Dublin, Ireland). Polypropylene tubes (15 mL, 
conical) were obtained from Sarstedt Ltd (Wexford, Ireland). Large volume SPE reservoirs 
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(150 mL) were purchased from Biotage (Uppsala, Sweden) and connected on top of the SPE 
cartridge using 1–6 mL adapters purchased from UCT Ireland Ltd, (Wexford, Ireland). Final 
extracts were filtered through Captiva Econo PTFE 0.2 µm filters from Agilent Technologies 
Ltd. (Cork, Ireland).  
A number of different SPE cartridges were assessed as part of the initial method development 
steps for sample preparation and clean-up including: Isolute ENV+ (200 mg, 6 mL) and 
Isolute ENV+/C18 dual layered (400 mg, 6 mL) purchased from Biotage (Upsala, Sweden), 
STRATA-X (200mg, 6mL) (Phenomenex, Cheshire, UK), UCT Enviro-Clean HL-DVB (200 
mg, 6 mL) from United Chemical Technologies Ireland Ltd. (Wexford, Ireland), and Oasis 
HLB (200 mg, 6 mL) and Oasis MCX (500mg, 6mL) from Waters (Dublin, Ireland). The 
analytical UHPLC column chemistries assessed for the chromatographic separation included: 
Luna Omega Polar C18 (50 × 2.1 mm, 1.6 μm) (Phenomenex, Cheshire, UK), Selectra PFPP 
(100 × 2.1 mm, 3.0 μm) (UCT, Wexford, Ireland), Triart C18 (100 × 2.0 mm, 1.9 μm) (YMC, 
Kyoto, Japan) and Zorbax Eclipse Plus Phenyl-Hexyl Rapid Resolution HD (100 × 3.0 mm, 
1.8 μm) (Agilent, Cork, Ireland). 
2.2 Preparation of standard solutions 
Individual primary stock solutions were prepared by dissolving the appropriate weight of 
certified standard material in suitable solvents, selected based on solubility. CLOP (0.5 mg 
mL
-1
), DIAV, HALO, NICARB, NITRO (all 2 mg mL
-1
), DICLAZ and ROB (both 4 mg mL
-
1
) were prepared in DMSO. NEQUIN, BUQUIN and DECO (0.1, 1 and 2 mg mL
-1
 
respectively) were prepared in 10% (v/v) formic acid in MeCN (quinolone solvent). ETHO (2 
mg mL
-1
) was prepared in MeCN, while all remaining analytical standards were prepared in 
MeOH at a concentration of 2 mg mL
-1
, except CYROM, MAD, NAR and ROX which were 
prepared at 4 mg mL
-1
. All deuterated or labelled internal standards were prepared at a 
concentration of 1 mg mL
-1
, in the same solvent as their corresponding analyte, from which a 
mixed intermediate solution was prepared for all internal standards, except DECO-d5 which 
remained separate. Internal standards requiring MeOH, were prepared in MeOH-d. 
Six mixed intermediate solutions were prepared at a concentration of 25 µg L
-1
, each 
containing different analytes as specified in Table 1 (Std. Group A–F). In addition, 1 µg mL-1 
intermediates were prepared for groups A-D. All intermediates were prepared in MeCN, 
except group C intermediates, which were prepared in quinolone solvent. This solvent was 
incorporated based on the work carried out by Moloney et al.[1], who reported the necessity 
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of the added formic acid to keep the group C analytes in solution. A set of eight mixed 
working calibration solutions (Calibrants 1–8) were prepared in MeCN by dilution of the 
respective intermediate mixed working solution (A, B and D-F), as described in 
Supplementary Table S1. A second series of calibrants for group C compounds were prepared 
in quinolone solvent. All working solutions were stored at -18 °C or below in glass amber 
vials with equilibration to room temperature before use.  
2.3 UHPLC-MS/MS determination 
Instrumental determination was performed using an Agilent 1290 Infinity™ II UHPLC 
system (equipped with an 8 tray multi-sampler and dual needle injector), coupled to an AB 
Sciex 6500+ quadrupole linear ion trap (QTRAP) mass spectrometer with IonDrive™ 
technology including a Turbo V source, an IonDrive QJet Guide and an IonDrive High 
Energy Detector+ (HED). The mass spectrometer was controlled using Analyst® software 
provided by Sciex (Version 1.7.0.). An Analyst® Device Driver (ADD) application (Version 
1.3) provided by AB Sciex, was necessary to interface and control the Agilent LC. Data was 
processed and reviewed using MultiQuant™ (version 3.0.3) provided by AB Sciex.  
2.3.1 UHPLC conditions 
All analytes were chromatographically separated on an Agilent Zorbax Eclipse Plus Phenyl-
Hexyl Rapid Resolution HD threaded analytical column (100 × 3.0 mm, 1.8 μm particle size) 
fitted with an in-line filter (0.2 µm pore size). A binary gradient elution was performed using 
2mM ammonium formate + 0.01% formic acid in water (mobile phase A) and 0.1% formic 
acid in MeCN (mobile phase B), at a flow rate of 0.6 mL min
-1
. The gradient starting 
condition was 99.9% mobile phase A, with the profile as follows: 0.0–2.0 min (99.9% A), 
2.0–4.0 min (70% A), 4.0–8.0 min (30% A), 8.0–11.0 min (30% A), 11.0–13.0 min (0.1% A), 
13.0–14.5 min (0.1% A), 14.50–14.6 min (99.9% A) and 14.6–16.5 min (99.9% A). An 
integrated divert valve was incorporated to divert the LC flow to waste for the first and last 2 
min of the gradient. Extracts were injected in pure DMSO, using a 2.5 µL injection volume. 
The autosampler needle was rinsed after each injection with a H2O:MeOH:IPA (40:40:20, 
v/v) solution, while a H2O:IPA (90:10, v/v) solution was used for seal wash. The column 
temperature was maintained at 40 ± 1 C while the auto-sampler was maintained at 20 °C to 
prevent solidification of the DMSO extracts. 
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2.3.2 MS/MS conditions 
Anticoccidial residue detection was performed using an electrospray ionisation interface with 
rapid polar switching i.e. in both ESI positive (+) and negative (-) mode. Data was gathered 
using multiple reactions monitoring (MRM) mode with the acquisition segmented to produce 
MRM windows around each analyte retention time with a span of 60 or 90 s, dependent on 
the peak width. Transitions were selected and adapted from the in-house methods described 
by Moloney et al. [1], with some additional compounds included. Compound specific 
parameters were tuned using a teed infusion of individual compounds (100 or 500 ng mL
-1
), 
using a Hamilton syringe (10 µL min
-1
), into the MS source with mobile phase (A:B, 50:50 
v/v, 0.6 mL min
-1
). Generic source conditions were used to allow sufficient desolvation and 
ionisation in the source (± 4500V, 450
o
C, curtain gas pressure 20 psi and GS1 and GS2 both 
at 40 psi). The transitions followed for each analyte are as summarised in Table 1. The 
MS/MS source conditions were then optimised for the least sensitive analytes using flow 
injection analysis (FIA) and the final optimised conditions are summarised as follows: ion 
spray voltage (+)4500V/(-)4500V; source temperature 550
o
C; collision gas nitrogen (N2); 
CAD gas High; entrance potential (EP) 10 volts; curtain gas pressure 40 psi; ion source gas 1 
(GS1) pressure 60 psi; ion source gas 2 (GS2) pressure 60 psi and Q1/Q3 unit resolution. 
Collision energies (CE) and de-clustering potentials (DP) were optimised for each fragment, 
and are also summarised in Table 1.  
2.4 Sample Collection, Control Samples and Quality Control  
Samples were collected in the same manner as previously described by the authors in 
discussing the analysis of anthelmintic drug residues [28]. Samples were stored in the dark at 
4 °C until analysis, which was always carried out within 10 days of collection, as determined 
by matrix stability studies. Control samples were also produced as described in the previous 
paper [28], with the exception of the negative control and QC samples, which in this instance 
consisted of a 250 mL negative control aliquot contained in a 500 mL glass amber bottle. 
Similarly, internal QC checks consisted of system suitability checks, negative control 
samples, solvent blank injections and retention checks. 
2.5 Procedural Matrix Calibration 
Matrix calibration curves were prepared by fortification of negative control water samples 
(250 mL) with 100 µL of both sets of calibrant standards (Calibrant 1–8) as described in 
Appendix A Table A1. An additional lower calibration point was produced for some analytes 
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by fortification with 100 µL of a solution consisting of Calibrant 1 diluted 1 in 5, while an 
additional higher calibration point was produced by fortification with 200 µL of calibrant 8 
(i.e. 2 × Cal 8). For each analyte, a minimum of 8 points were used to construct a calibration 
curve, with the individual calibration range for each analyte shown in Table 2 above. All 
calibrants, quality control samples and samples were fortified with the working mixed 
internal standard solution (100 µL) and DECO-d5 (100 µL), corresponding to sample 
concentration of 100 ng L
-1
 for CYROM-d4, DECO-d5, ETHO-d5, HALO-HBr 
13
C6 and 
ROB-d8 and 500 ng L
-1
 for DNC-d8 and IMIDO-d8. 
2.6 Sample preparation - Final SPE method  
Water samples were weighed (250 ± 0.1 g corresponding to 250 ± 0.1 mL) directly into glass 
amber bottles (500 mL) and equilibrated to room temperature. Extracted matrix calibrants 
were fortified with the working calibrant solutions, with internal standard added to all 
calibrants, controls and test samples, as described above (Section 2.5). All samples were 
shaken (60 s), modified with MeOH (7.5 mL), and shaken again (60 s). Samples were 
subsequently adjusted to pH 8.5 ± 0.05 with NH4OH (0.5M and/or 0.1M). The sample-
modifier mixtures (257.5mL) were extracted using UCT Enviro Clean HL DVB (200 mg, 6 
mL) SPE cartridges packed with glass wool (2.5 ± 0.2 g). Prior to loading, SPE cartridges 
were conditioned with MeOH:MeCN (50:50, v/v) (5 mL), MeOH (5 mL) and equilibrated 
with UPW, pH 8.5 (5 mL). Samples were loaded under vacuum at a rate of 5–6 mL min-1. 
Once loaded, samples bottles were rinsed with H2O: MeOH (95:5, v/v) (10 mL) and added to 
the SPE cartridge. The SPE cartridges were then washed with a further aliquot of H2O: 
MeOH (95:5, v/v) (5 mL). Cartridges were dried under vacuum (30 mins) and eluted with 
MeOH:MeCN:EtOAc (40:40:20, v/v) (3 × 4 mL) into 15 mL polypropylene tubes. DMSO 
(500 µL) was added to each sample as a keeper solvent and then vortexed (30 s). Samples 
were concentrated under nitrogen using a TurboVap LV (50°C, 15–20 psi, 60–90 min). 
Extracts (in 500 µL DMSO) were sonicated (5 min) and vortexed (60 s) prior to filtration 
through 0.22 µm syringe filters into glass HPLC vials (Waters; Dublin, Ireland) containing 
300 µL glass inserts, for instrumental determination. 
2.7 Method Validation procedure 
There are no definitive legislative validation guidelines available pertaining to the 
performance of analytical methods for the determination of veterinary pharmaceuticals in 
environmental water samples. As a result the developed method was validated using a similar 
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approach to that previously described by the authors of this work [28], using an 
amalgamation of validation criteria from SANTE/11813/2017 (guidelines for pesticides in 
food) [29] and European Legislation 2002/657/EC (guidelines for veterinary residues in food) 
[30]. Validation was performed at four concentration levels (Table 3) across the calibration 
curve, and around a target level (TL) of 100 ng L
-1
 (set based on pesticide legislation in 
drinking water [31] and groundwater [32]), to be consistent with the method sensitivities for 
the different analytes. Identification, specificity, selectivity, matrix effects, limits of detection 
and limits of quantification were all assessed as per the Mooney et al. approach [28]. 
Linearity was assessed by examining calibration curves produced with a minimum of 8 points 
using a 1/x
2
 fit, on five different occasions. Trueness and Precision as relative standard 
deviation (RSD) were both assessed under within lab repeatability (WLr) and within lab 
reproducibility (WLR) conditions, using fortified negative control samples. The WLr study 
involved fortification at each of four validation levels in replicates of n = 8. For WLR, a total 
of n = 29 replicates at each validated concentration level, were analysed over 5 different days 
(n = 6 on each day, except one day with n = 5). Matrix effects (ME) were assessed similarly 
using the post extraction spiking method as described by Matuszewski et al. [33], using 25 
negative control samples from different sources. ME were assessed at two concentration 
levels, equivalent to calibrant L2 and L7 for each analyte. The criteria adhered to for each 
parameter are specified in Supplementary Information Table S2. 
3. Results and Discussion 
3.1. Method development:  
3.1.1 UHPLC-MS/MS  
Precursor and product ions were assessed by teed infusion of individual analytes along with 
mobile phase into the MS, with detection using generic source parameters that were further 
optimised by flow injection analysis (FIA) once transitions were selected (final conditions as 
in Section 2.3.2). This approach was used as mobile phase was necessary to assist with the 
formation of particular adducts.The product ion transitions obtained and selected (Table 1) 
were in agreement with the in-house method developed by Moloney et al. [1] and consistent 
with those reported amongst literature, as summarised by the Clarke et al. review [3]. 
NICARB was detected as its active component dinitrocarbanilide (DNC). Semduramicin-
sodium was detected and fragmented using the 890 m/z precursor, which is produced by loss 
of the free sodium and subsequent formation of an ammonium adduct (895.1 - 23 + 18 m/z). 
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Fragments (833.2 m/z and 851.1 m/z) were also obtained for the protonated semduramicin 
sodium molecular ion (896 m/z), however intensities were not very reproducible. TOL, TOL-
SO and TOL-SO2 proved difficult to fragment in either ESI (+) or (-), as experienced and 
discussed by previous authors. No product ions were achieved for TOL-SO and TOL-SO2, 
however some product ions were obtained for TOL, as follows: m/z 371, m/z 367, m/z 99 and 
m/z 42. The authors were unable to verify any of these transitions given that no other method 
has been published with similar product ions, except for m/z 42, which may be unspecific and 
prone to background interference for such a small fragment ion.  
A number of additional compounds, not included in the Moloney paper [1], were 
incorporated as highlighted in Table 1. Tuning experiments, for the majority of these 
compounds, showed protonated [M + H]
+
 molecular ions, with the exception of NITRO and 
DINITOL (dinitolmide also called zoalene) which formed deprotonated [M – H]- ions. The 
products formed from these additional compounds were in agreement with those included in 
the Clarke et al. review, or other literature [34-36], with the exception of AKLO and ANOT. 
Clarke et al. noted that AKLO does not easily fragment, thus is monitored using the 
deprotonated [M – H]- m/z 199 only, and therefore is unsuitable for confirmatory analysis. In 
this current work, AKLO was monitored using the protonated molecular ion m/z 201, with 
product ions observed at m/z 183, 155, 138 and 110, with the m/z 138 and 155 ions selected 
as quantifier and qualifier ions respectively. The quantifier ion monitored in this experiment 
for ANOT was consistent with other reported literature, however a m/z 133 qualifier fragment 
monitored by Wu et al. [37] was not observed in this current work. Instead, a m/z 153 ion was 
monitored as a qualifier, likely formed by cleavage of the amide group.  
Four different UHPLC column chemistries were assessed, namely PFPP, Triart C18, Omega 
polar C18 and phenyl-hexyl. Initial work indicated that both the PFPP and phenyl hexyl 
columns showed good retention of most compounds, including the problematic highly polar 
compounds, which are not well retained by reversed phase chromatography chemistries and 
are normally analysed by HILIC phases. Further assessment of the PFPP indicated problems 
with drifting and inconsistent retention times for a number of compounds including CLOP, 
IMIDO, ISOMET and NAFAM. It is proposed that this issue is likely due to the capability of 
the PFPP stationary phase to operate in both reversed phase and HILIC mode, where the very 
polar basic compounds are retained initially by reverse phase interactions; however as the 
percentage of organic phase increases, the retention mechanism switches to HILIC mode. 
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Efforts to address this issue resulted in a significantly increased run time, and as a result 
PFPP was omitted from further consideration, with phenyl-hexyl selected for final 
consideration. The particular phenyl-hexyl phase used contains a special high purity 
ZORBAX support that is designed to reduce or eliminate strong adsorption of basic and 
highly polar compounds. 
A number of authors have reported improved retention and peak shape for a number of 
anticoccidials by incorporation of formic acid (HCOOH) into mobile phases [1, 34], therefore 
the effect of varying concentrations of HCOOH (0.01–1%, v/v), in both A and B mobile 
phases, was assessed using the phenyl hexyl column. Acetic acid was also assessed as a 
commonly used alternative additive. Chang et al [34] also reported the use of ammonium 
formate to further improve peak shape, and hence, varying concentrations (1–10 mM) of 
ammonium formate in mobile phase A were also assessed. Optimal results for 31 different 
anticoccidial compounds were achieved when using a binary gradient separation on the 
phenyl hexyl column using a 0.01% HCOOH and 2 mM ammonium formate aqueous phase 
(mobile phase A) and a 0.1% HCOOH in MeCN organic phase (mobile phase B). Higher 
concentrations (0.1%) of HCOOH in mobile phase A, had a negative effect on peak shape 
and intensity for some analytes, as did the use of the acetic acid additive. In addition, a 
number of different injection solvents, including DMSO, EG and H2O:MeCN (80:20, v/v) 
were assessed, with DMSO achieving better sensitivity and peak shape for a number of 
compounds, including AMP and CYROM.  
The gradient profile was optimised in order to reach optimal chromatographic separation, 
with the overall conditions as previously described in Section 2.3.1. All 31 anticoccidials and 
the six internal standards were successfully eluted within the first 12 minutes of the gradient, 
as demonstrated by the extracted ion chromatograms (EIC) in Figure 1. After elution of the 
compounds, the gradient was held at 99.9% B for 1.5 min to remove any less polar co-
extractives from the column. During this period the LC continued to flow directed into the 
MS source, with the organic solvent anticipated to provide some cleaning of the ion source 
probe and spray plate. Subsequently, the gradient was returned to the starting point (99.9% 
A), with a minimum 2 min hold determined to be necessary for column re-equilibration. On 
injecting a solvent standard on a number of different occasions (5 different runs), the gradient 
was found to be robust and reproducible, with the variation in retention times for all analytes 
≤0.02 min (Table 2), except for AMP (≤0.03 min) and ISOMET (≤0.08 min). All analytes 
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satisfied the SANTE criterion (± 0.1 min)[29]. Retention was also verified by injection on 
columns with different product batch numbers, with no adjustment necessary to retention 
windows.  
3.1.2. Sample Preparation  
The development and optimisation of a SPE procedure for anticoccidials was carried out 
using an approach similar to that described for anthelmintic residues [28], with the main steps 
depicted in Figure 2. Six different polymeric sorbents (described in Section 2.1) were 
assessed as part of this work for the extraction of anticoccidials from water, given that they 
are the most commonly used amongst literature [20-26]. These included five different 
reversed phase sorbents and one mixed mode phase used for the extraction of basic 
compounds with cationic functional groups. The HLB, ENV+ and HL-DVB cartridges all 
performed similarly, with satisfactory recovery (>70%) for the majority of analytes, with the 
exception of CLOP, DIAV, HALO, IMIDO, ISOMET, NAFAM and PENT, which gave 
lower recovery (<50%), while AMP and CYROM demonstrated recoveries of 50 and 60% 
respectively. The dual layered ENV+/C18 cartridge also showed similar results, although the 
loading rate was much slower and a higher vacuum required. Recoveries of a number of the 
poorly recovered basic compounds were improved using the MCX cartridge, however this 
was at the expense of less basic and neutral compounds such as the toltrazurils (TOL, TOL-
SO and TOL-SO2), NICARB, DICLAZ and the quinolones (BUQUIN, DECO AND 
NEQUIN) which were not retained on this sorbent phase. Overall the HL-DVB cartridge was 
selected for further assessment, given that better reproducibility (all <15% RSD) and more 
consistent flow rates were achieved compared to the other cartridges.  
 
Further spiking experiments were carried out to assess the recovery of analytes on the HL-
DVB cartridge. On spiking directly onto the cartridge (as opposed to loading in water), all 
analytes achieved satisfactory recoveries (69–116%) except HALO (22%), indicating that 
recovery losses occurred prior to, or during, the loading of samples onto the SPE cartridge. 
To further improve recovery, six different elution solvent compositions (described in Figure 
2) were assessed, with the elution volume restricted to 12 mL due to tube size and 
evaporation time in the TurboVap LV evaporator. MeOH, MeCN and MeOH:MeCN (50:50, 
v/v) gave the best overall recovery results, but the MeOH:MeCN mixture provided better 
precision. Results indicated that EtOAc did not improve the recovery of analytes, however it 
provided enhanced sensitivity for analytes including the toltrazurils and two ionophores, 
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namely, NAR and SAL. This was attributed to the more hydrophobic EtOAc extracting fewer 
polar interferences. Additional elution compositions incorporating EtOAc were assessed, 
with the overall optimal elution solvent determined to be MeOH:MeCN:EtOAc (40:40:20, 
v/v). On assessing elution volumes, the 12 mL volume was maintained given there was no 
significant increase in recovery with the larger volumes. Following optimisation of the 
elution conditions, further experiments were carried out to identify the possible cause of 
lower recoveries for some analytes, namely AMP, CYROM, HALO, IMIDO, ISOMET, 
NAFAM and PENT. Breakthrough experiments (two stacked cartridges eluted and analysed 
separately) showed minimal breakthrough of analytes. Analysis of the sample bottle rinsate 
(rinsed with elution solvent) indicated that there was minimal adsorption of analyte to the 
bottle given that no more than 5% of any analyte was detected in rinsate. 
 
The Water Framework Directive [38] and the Environmental Quality Standards Directive 
[39] require the measurement of “whole water” concentrations of pollutants (including both 
dissolved fractions and suspended solid fractions). Filtration of water samples prior to 
analysis may consequently remove any contaminants sorbed to suspended solids in the 
sample, therefore does not allow for the measurement of whole water concentrations. Glass 
wool was incorporated into the SPE procedure to allow for the analysis of the water without 
filtration, with the glass wool eluted simultaneously with the SPE cartridge. The glass wool 
was also necessary to prevent blocking of the SPE cartridge by the unfiltered samples. In 
order to investigate the effect of the glass wool on recovery, experiments were carried out 
using ultrapure water in which analytes were extracted with and without glass wool, assessing 
both silanised and unsilanised glass wool. Results indicated that IMIDO, ISOMET, NAFAM 
and PENT were strongly retained to active sites on the unsilanised glass wool, with 
subsequent elution failing to remove these analytes from the glass wool. However, use of the 
unsilanised glass wool proved beneficial for a number of analytes (AMP, ARPRIN, CLOP 
and CYROM) with up to a 70% improvement in recovery compared the use of silanised or no 
glass wool, indicating that the recovery of these compounds was primarily due to adsorption 
to the unsilanised glass wool, as opposed to retention on the sorbent. Overall, better 
recoveries were achieved for a greater number of analytes using the unsilanised glass wool. 
 
Sample modification experiments assessed the use of organic modifier (MeOH, 0–30%) and 
pH adjustment (pH 2–10) to address the retention of analytes to the unsilanised glass wool. 
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Addition of >10% MeOH modifier demonstrated a notable decrease in recovery for a few 
compounds (e.g. AMP and CYROM), with recoveries dropping below 20%, while 15 other 
analytes showed a slight improvement in recovery with higher modifier, particularly the 
ionophores. Further experiments looked at refinement of the modifier, with the addition of 
3% MeOH modifier selected as the optimum, despite no improvement in recovery of IMIDO, 
ISOMET, NAFAM and PENT. These findings are somewhat consistent with those reported 
by Song et al. [22] who reported the use of approx. 9% MeOH. A pH range between 8.5 and 
10 produced the best overall results, with improved recovery demonstrated for a number of 
compounds, namely the ionophores, AMP, CYROM and HALO. A pH of 8.5 was selected 
for the final method, given that there was evidence of precipitation of some compounds when 
the pH was adjusted to 10. The improved recovery of AMP and CYROM is proposed to be 
due to reduced adsorption of analyte on the glass wool, and more retention on the reversed 
phase sorbent as the analytes are fully unionised at the higher pH. This selected pH is also 
consistent with the findings of the Hansen et al [4] review, which suggested a range of pH 7–
9, as reported amongst literature, to be sufficient for extraction of the ionophore 
anticoccidials. At pH values greater than their pKa (reported as 4–8 [4, 21, 40]), the 
ionophores remain un-protonated and form neutral highly lipophilic complexes with cations, 
allowing for better retention on the reverse phase SPE.  
 
The overall optimised conditions for the final method (as described in Section 2.6) were 
assessed at two levels (one low and one high), with concentrations of each analyte equivalent 
to calibrant L2 and calibrant L7 respectively. The overall recovery results are as presented in 
Figure 3. The SPE procedure was unsuitable for the extraction of four compounds (IMIDO, 
ISOMET, NAFAM and PENT), due to what is proposed to be the lack of retention on the 
cartridge, or the retention and insufficient elution of analyte from the glass wool. For the 
other analytes, at the lower concentration, the recoveries ranged from 81–105%, with 
precision ranging from 0.9–8.8% RSD. At higher concentrations, recovery of some analytes 
was slightly lower, however the minimum criteria were satisfied (recovery of 70–120%) with 
recoveries ranging from 77–105% and precision between 0.8–5.8 %.  
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3.2. Method validation 
3.2.1 Identification 
For each compound, one precursor and two daughter ions were monitored giving a total of 
four identification points, satisfying the confirmation criteria set out in 2002/657/EC. In some 
cases (e.g. DICLAZ), five points were achieved by monitoring two different precursor ions. 
TOL, TOL-SO and TOL-SO2 failed to meet confirmatory criteria due to insufficient 
identification points, as a result of the poor fragmentation, commonly reported amongst 
literature. However, these three analytes were still incorporated for screening purposes. The 
2002/657 criterion for relative retention time (RRT, ≤2.5% deviation) was adhered to and 
satisfied for all analytes. For ion ratio (R, relative intensities), the SANTE criterion of 30% 
(ΔR) was applied, given the value specified in 2002/657/EC varied from 20–50% (ΔR) 
depending on the magnitude of the value. In this work, the ion ratio criteria of < 20% 
deviation were for the majority of analytes. 
3.2.2 Specificity, Selectivity Linearity, Limits of Detection (LOD) and Limits of 
Quantification (LOQ) 
No cross-talk or isobaric interferences were observed on injecting analytes and internal 
standards. The selectivity of the method was initially evaluated through application to 30 
different groundwater and surface water samples collected from different sources. No major 
matrix interference peaks were observed at the same retention time of the analytes. 
Linearity was assessed by visual inspection of calibration curves and by verification of 
residuals and coefficient of determination (R
2
) values. Acceptable linearity was set as R
2
 ≥ 
0.98 (2002/657) and residual deviations of no greater than ± 20% from the calibration plot. 
The majority of curves were produced with using a linear fit and 1/x
2 
weighting, however a 
number of analytes (ARPRIN, CLOP, DIAV, BUQUIN and NEQUIN) required a quadratic 
fit, attributed to the detector approaching saturation at the higher concentrations. For almost 
all analytes, mean R
2
 values (n = 5 runs) were >0.99 (Table 2) meeting the validation 
criterion. The one exception was ROX, with insufficient linearity achieved through all 
validation runs, thus this analyte was omitted from the method. 
The LOQ was determined as the lowest spiking level which satisfied the method performance 
criteria set out by SANTE for trueness and precision, in combination with the minimum 
signal to noise (S/N) (Supplementary Table S2). The LOQ for the majority of analytes 
corresponds to the lowest calibrant level of the calibration curve, ranging from 0.1–20 ng L-1 
as summarised in Table 3. Adhering to minimum performance capabilities specified for 
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pesticides under Council Directive 98/83/EC [31] and assuming similar applicability to 
anticoccidials, the method LODs were required to be ≤ 25 ng L-1 (calculated as ≤ 25% of the 
specified parametric value for pesticides of 0.1 µg L
-1
). LODs, as summarised in Table 3, 
ranged from 0.005 to 5 ng L
-1 
(ppt; parts-per-trillion), thus all analytes satisfied the minimum 
performance capability criterion. In terms of sensitivity, this developed method performs 
similar to, or better than other methods (see Section 4), with detection capabilities as low as 
part-per-quadrillion (ppq; pg L
-1
) levels.  
3.2.3 Matrix effects (ME) 
Traditionally, ME are calculated using the formula first described by Buhrman et al.[41] :  
                        (Eq. 1) 
where A is the response of analyte in neat solvent and B is the response of analyte at the same 
concentration, in post spiked matrix extracted samples. However, this approach can be 
counter-intuitive, given that a resulting negative ME value represents ion enhancement 
(increase in response), while a positive value indicates ion suppression (decrease in 
response). In an attempt to avoid such confusion, Matuszewski et al. [33] used an adapted 
approach whereby they measured ME as “absolute ME” calculated as (B/A × 100), in which 
a resulting ME value >100% indicated ion enhancement, while values <100% indicated 
suppression.  
In this paper, a similar approach to Matuszewski et al. was used, where matrix effects were 
assessed at two levels, one low (Cal L2) and one high (Cal L7), and calculated as follows:  
                      (Eq. 2) [42] 
Using this approach, negative (-) ME values indicated suppression (decrease in analyte 
response due to endogenous and/or exogenous matrix components), while positive (+) values 
indicated enhancement (increase in analyte response due to matrix components). The mean 
matrix effects (n = 25) of analytes at the higher concentrations (equivalent to Cal L7, 
validation L4) ranged from –12% for DINITOL (analyte suppression) up to +5% for MAD 
(enhancement), satisfying the SANTE criteria (ME ± 20%). The range of ME for each 
individual analyte across the entire 25 samples is shown in Table 2. The most suppression in 
any one sample was 22% (ME -22%) for ANOT (as demonstrated in Figure 4(b)), while the 
highest enhancement in any one sample was observed for MAD (+18%) (Figure 4(a)). Very 
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good precision was demonstrated between the 25 different samples, with RSD values for each 
analyte ranging between 1.3 and 7.2%. At lower concentrations (equivalent to Cal L2, 
validation L1) the effect of matrix was slightly more prominent, with the mean ME ranging 
from -22% (suppression) to +24% (enhancement). Precision at the lower concentration, 
however, was still satisfactory, with RSD for all analytes <9.9%. Isotopically labelled 
internal standards were incorporated into the method for six anticoccidials, with the precision 
further improved for these six analytes when the IS was employed for quantification. Suitable 
internal standards were not available for the majority of analytes and as a result matrix 
calibration was employed to address any potential matrix effects, further satisfying validation 
criteria. 
3.2.4. Trueness and Precision 
Trueness criteria were set as 70–120% based on SANTE guidelines, while precision (in terms 
of RSD) was set as ≤20% as the 2002/657/EC guidelines were not appropriate. Trueness and 
precision data for WLr and WLR conditions are summarised in Table 3. Under WLr 
conditions, the trueness across the four validation levels ranged from 86–114%, with all 
analytes meeting the set criteria. The trueness for all analytes under WLr conditions at the 
lowest validation level was >95%, demonstrating very high accuracy even at ppq (pg L
-1
) to 
ppt (ng L
-1
) levels. WLr precision (RSDr) for all analytes across the four validation levels was 
in the range of 0.5–8.2%. For a number of analytes such as NEQUIN and BUQUIN, the WLr 
trueness decreased with increasing concentration, however it was were still acceptable. Under 
reproducibility conditions (WLR), trueness ranged from 88–111%, with all analytes meeting 
the acceptance criteria. Precision for the majority of analytes under reproducibility conditions 
(RSDwR) WAS <5%, with the overall range between 0.9–10.3%. Overall this method has 
been shown to be very accurate and precise for the 23 confirmatory analytes and three 
screening analytes (TOL, TOL-SO and TOL-SO2). 
3.3 Applicability  
The method presented above has been applied for the determination of the 26 anticoccidial 
compounds as part of a spatial sampling programme, whereby >100 groundwater samples 
were collected from sites throughout the Republic of Ireland during November/December 
2018. Seven different anticoccidial compounds, consisting of four ionophores (lasalocid, 
monensin, narasin and salinomycin) and three chemical coccidiostats (amprolium, diclazuril 
and nicarbazin), were detected during the sampling campaign. The concentration ranges of 
         
21 
 
each anticoccidial detected are as shown in Table 4. Further information and details of this 
spatial occurrence study are currently in preparation for publication. 
4. Comparison with other existing methods for environmental water samples 
As highlighted in the introduction, based on literature review, there are very few methods 
available for the determination of anticoccidial residues in water samples, with the majority 
of methods reported being for the separate analysis of ionophores [20, 21, 24, 25, 27] or a 
limited number of chemical anticoccidials [43]. The method proposed by Herrero et al. [27] 
extracted five ionophores (LAS, MAD, MON, NAR, SAL) from river water using HLB 
(150mg) SPE cartridges, with good recoveries reported, ranging from 89–97%. An LOQ of 1 
ng L
-1
 was reported for all analytes except MAD (5 ng L
-1
), with LODs ranging from 0.5 -1 
ng L
-1
. Martinez-Villalba et al. [19] proposed a method for the determination of eight 
anticoccidials (including the three chemical anticoccidials DICLAZ, NICARB and ROB) 
using C18 SPE. Recoveries of all analytes were in the range of 85–100% except for ROB 
(60%), while LODs were in the range of 11–71 ng L-1. The method developed as part of this 
study is capable of determining 26 anticoccidial compounds, including six ionophores and 20 
chemical anticoccidials. This new method performs better for all of the analytes reported by 
Herrera et al., with LOQs of 0.1 ng L
-1 
for LAS, MON, NAR and SAL and 1 ng L
-1
 for MAD. 
Similarly, detection capabilities of this developed method are much improved compared to 
the results reported by Martinez-Villalba et al.. In particular, this work reports higher 
recovery of ROB, with lower reported detection limits (at least 50 times lower) for the three 
chemical anticoccidials reported by Martinez-Villalba et al. This new method allows for 
detection limits down to the part-per-quadrillion (pg L
-1
) level, depending on the analyte. 
5. Conclusions 
A comprehensive LC-MS/MS detection method has been developed which allows for the 
simultaneous separation and detection of 31 anticoccidial drugs in one single injection. A 
sample extraction procedure based on SPE has been developed and optimised for the 
extraction of these anticoccidial residues from raw, unfiltered, environmental water samples 
at ppq to ppt levels. This extraction procedure was suitable for extraction of 26 anticoccidials, 
with four compounds not retained by the SPE due to their high hydrophilicity. The method 
has been extensively validated for these 26 analytes, over a broad range of concentration 
levels, in-line with expected environmental levels, based on review of currently available 
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literature. The developed detection method is advantageous compared to other reported 
methods as it allows the simultaneous detection of highly polar, basic compounds such as 
amprolium and cyromazine, along with other analytes such as the ionophores, on the same 
analytical column. In addition, the combination of the developed SPE procedure with this 
detection method allows for the determination of a broader range of both ionophore and 
chemical anticoccidial residues (26), compared to currently available methods which 
incorporate <10 anticoccidials. Overall the method has been deemed fit for purpose for the 
confirmatory analysis of 23 anticoccidials, and screening of an additional three compounds 
(TOL, TOL-SO and TOL-SO2), according to appropriate validation guidelines.  
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Figure Captions 
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Figure 1. Overlay of LC-MS/MS extracted ion chromatograms (EIC) for all 31 anticoccidial 
analytes (positive mode (a-b) and negative mode (c)) at concentrations equivalent to calibrant 
level L2 (2.5/7.5/20/25 ng L
-1
) (Table A1), and the seven internal standards (d), in a fortified 
blank water sample. 
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Figure 2. Summary of the main steps carried out as part of the development and optimisation 
of the SPE procedure for extraction of anticoccidial residues from water. 
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Figure 3. Overall mean recoveries and precision (% RSD shown by error bars) (n = 3) for all 
anticoccidial compounds, at two concentrations using the final optimised conditions: 250 mL 
environmental water samples, modified with MeOH (7.5 mL) and pH adjusted to pH 8.5, 
extracted using UCT-HL-DVB (200mg, 6 mL) SPE cartridges, washed with MeOH:H2O 
(95:5, v/v) and eluted with MeOH:MeCN:EtOAc (40:40:20, v/v) (3 x 4 mL). 
 
 
 
         
31 
 
 
 
 
 
Figure 4. Extracted ion chromatogram (EIC) overlay of quantifier ions for a spiked solvent 
standard (grey) and spiked matrix sample (black), spiked at concentration equivalent to 
calibrant level L7 (125/200 ng L
-1
), demonstrating (a) response enhancement for 
maduramicin and (b) suppression for 3-ANOT, due to matrix effects. 
 
Appendix A 
Table A1. Preparation of matrix matched calibration, with corresponding sample concentrations 
Spiking Vol. 
(µL) 
Calibration Level 
Concentration Ranges (ng Lˉ¹) for Analyte Groupa: 
A B C** D E F 
100 0.2 × L1 0.1 0.1 0.1 1 2 4 
100 L1 0.5 0.5 0.5 5 10 20 
100 L2 2.5 2.5 2.5 7.5 20 25 
100 L3 10 10 10 10 40 50 
100 L4 50 50 50 50 50 75 
100 L5 100 75 75 100 75 100 
100 L6 150 100 100 150 100 150 
100 L7 200 125 125 200 125 200 
100 L8 250 150 150 250 150 250 
200 2 × L8 500 300 300 500 300 500 
a Analytes within each concentration range group are as specified in Table 1 ** group C analytes were spiked from a 
separate set of calibrants (1-8) which were prepared in MeCN +10% formic acid 
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Table 1.  UHPLC–MS/MS conditions for anticoccidial residues and respective internal standards 
Analyte 
Abbreviati
on 
Std.  
Grou
p 
tR
 
(mi
n) 
Pre-
ion 
(m/z
) 
Product 
Ions
a
 
(m/z) 
[M] 
D
P 
(V
) 
C
E 
(V
) 
CX
P 
(V) 
ESI 
Polari
ty 
IS 
Cyromazine-d4* CYROM-d4 IS 2.53 
171.
1 86.0 
[M+H]
+ 60 27 10 
+ None 
Cyromazine* CYROM D 2.56 
166.
9 
84.8/124.
9 
[M+H]
+ 30 25 12 
+ 
Cyromazin
e-d4 
Roxarsone* ROX F 2.90 
263.
8 
217.8/90.
9 
[M-H]- 
26 29 20 - None 
Amprolium* AMP A 3.61 
242.
8 
149.9/94.
0 
[M+H]
+ 60 17 14 
+ None 
Imidocarb-d8 IMIDO-d8 IS 4.00 
357.
1 191.9 
[M+H]
+ 26 39 22 
+ None 
Imidocarb IMIDO E 4.03 
349.
0 
187.9/162
.0 
[M+H]
+ 
12
0 33 14 
+ 
Imidocarb-
d8 
Nafamostat* NAFAM E 4.16 
348.
1 
162.0/186
.9 
[M+H]
+ 
12
0 23 8 
+ None 
Clopidol CLOP B 4.20 
191.
9 
100.9/86.
9 
[M+H]
+ 
13
1 39 10 
+ None 
ANOT* ANOT E 4.35 
196.
0 
106.9/153
.0 
[M+H]
+ 26 23 12 
+ None 
Diaveridine DIAV B 4.37 
261.
1 
122.9/244
.9 
[M+H]
+ 1 29 14 
+ None 
Pentamidine* PENT F 4.56 
341.
1 
324.1/120
.0 
[M+H]
+ 
12
1 43 12 
+ None 
Aklomide* AKLO F 5.11 
201.
0 
137.9/154
.8 
[M+H]
+ 36 37 16 
+ None 
Isometamidium* ISOMET F 5.13 
461.
1 
313.0/298
.0 
[M+H]
+ 36 29 16 
+ None 
Halo-HBr-13C6 HALO-
13C6 IS 5.26 
419.
9 138.0 
[M+H]
+ 60 25 16 
+ None 
Halofuginone-
HBr HALO A 5.27 
414.
3 
120.1/100
.1 
[M+H]
+ 61 27 14 
+ 
Halo-HBr-
13C6 
Arprinocid ARPRIN B 5.30 
278.
0 
142.9/106
.9 
[M+H]
+ 20 79 12 
+ None 
Nitromide* NITRO F 5.48 
209.
9 
166.9/62.
9 
[M-H]- -
20 
-
20 -17 - None 
Dinitolmide* DINITOL E 5.52 
223.
9 
181.0/77.
0 
[M-H]- -
15 
-
14 -21 - None 
Ethopabate- d5 ETHO-d5 IS 5.57 
243.
1 211.0 
[M+H]
+ 35 15 12 
+ None 
Ethopabate ETHO A 5.61 
238.
0 
135.9/206
.0 
[M+H]
+ 35 35 14 
+ 
Ethopabat
e- d5 
Robenidine-d8 ROB-d8 IS 6.88 
342.
0 342.0 
[M+H]
+ 
10
0 63 12 
+ None 
Robenidine ROB A 6.92 
334.
0 
154.9/137
.9 
[M+H]
+ 
10
0 27 18 
+ 
Robenidin
e-d8 
Toltrazuril-SO TOL-SO F 7.19 
440.
0 440.0 
[M-H]- -
15 -6 -11 - None 
Buquinolone* BUQUIN C 7.40 
362.
0 
316.0/203
.9 
[M+H]
+ 20 47 22 
+ None 
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Analyte 
Abbreviati
on 
Std.  
Grou
p 
tR
 
(mi
n) 
Pre-
ion 
(m/z
) 
Product 
Ions
a
 
(m/z) 
[M] 
D
P 
(V
) 
C
E 
(V
) 
CX
P 
(V) 
ESI 
Polari
ty 
IS 
Nequinate* NEQUIN C 7.50 
366.
0 
200.9/144
.9 
[M+H]
+ 20 61 16 
+ None 
DNC-D8 DNC-d8 IS 7.66 
308.
9 140.8 
[M-H]- -
30 
-
16 -15 - None 
4’4’’-
dinitrocarbanilid
e**  NICARB** D 7.69 
300.
9 106.8 
[M-H]- 
-
35 
-
52 -13 
- DNC-D8 
Toltrazuril-SO2 TOL-SO2 F 7.86 
455.
9 455.9 
[M-H]- -
50 
-
12 -23 - None 
Diclazuril DICLAZ A 8.32 404.
8 
406.
8 
333.7 
335.7 
[M-H]- 
[M-H]- 
-
10 
-
10 
-
28 
-
28 
-35 
-25 
- 
None 
Toltrazuril TOL D 8.38 
423.
9 423.9 
[M-H]- -
20 
-
10 -5 - None 
Deco-d5 DECO-d5 IS 8.73 423.
1 
377.1 [M+H]
+ 
13
0 
33 20  None 
Decoquinate DECO C 8.75 
418.
1 
372.1/203
.9 
[M+H]
+ 
13
0 55 22 + None 
Semduramicin SEMD A 9.43 
890.
4 
629.3/727
.2 
[M-Na 
+NH4]
+ 80 37 4 
+ None 
Lasalocid LAS A 
10.0
3 
613.
2 
377.1/595
.1 
[M+Na
]+ 
13
0 53 20 
+ None 
Monensin MON A 
10.3
3 
693.
0 
675.2/461
.1 
[M+H]
+ 80 55 36 
+ None 
Salinomycin SAL F 
10.8
3 
773.
1 
431.1/531
.1 
[M+H]
+ 
12
0 69 22 
+ None 
Maduramicin MAD D 
11.3
3 
934.
4 
629.4/647
.4 
[M+H]
+ 60 41 20 
+ None 
Narasin NAR A 
11.7
5 
787.
3 
431.0/531
.1 
[M+Na
]+ 91 71 22 
+ None 
tR= Retention time, M Wt = molecular weight, Pre-ion  = precursor ion, m/z = mass to charge ratio, [M] = 
molecular ion, DP = declustering potential, CE= collision energy, CXP = collision cell exit potential, ESI polarity 
mode; (+) = positive mode and (-) = negative mode IS= internal standard a Quantification Ion (bold) / Qualifier 
Ion                                    * denotes additional compounds included in this method, that were not included in the 
Moloney et al. method [1],                                                                                                                           ** Nicarbazin 
(NICARB) detected as 4’4’’-dinitrocarbanilide 
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Table 2. Retention time, calibration range, mean linearity (of n = 5 runs) and results of matrix effects 
(ME) at two concentrations (n = 25) for each of the 26 anticoccidials 
Analyte 
tR ±SD 
min 
Calibration 
Range 
(ng L
-1
) 
Linea
rity 
R
2
 
Mean ME 
(%) (n-25) 
ME RANGE (%) RSD 
(n=25) (%) [Low] [High] 
[Lo
w] 
[Hi
gh] 
Mi
n 
Ma
x 
Mi
n 
Ma
x 
No 
IS 
With 
IS 
Aklomide 
5.11 ± 
0.01 20.0 - 250 
0.996
6 8.6 1.2 
-
5.9 
19.
9 
-
13.
3 
13.
0 
6.
8 
- 
Amprolium 
3.61 ± 
0.03 0.5 - 250 
0.999
5 3.3 2.5 
-
0.3 
10.
2 
-
3.9 8.7 
2.
8 - 
ANOT 
4.35 ± 
0.01 10.0 - 150 
0.998
2 0.7 -2.9 
-
7.8 
10.
4 
-
21.
9 
11.
8 
7.
2 
- 
Arprinocid 
5.30 ± 
0.00 0.5 - 150 
0.999
6 8.9 2.1 2.6 
15.
5 
-
4.2 7.4 
2.
9 - 
Buquinolone 
7.40 ± 
0.00 0.5 - 150 
0.999
3 7.1 -0.2 0.1 
12.
0 
-
4.8 3.7 
2.
1 - 
Clopidol 
4.20 ± 
0.00 0.5 - 150 
0.999
6 7.3 2.6 
-
1.2 
13.
8 
-
3.3 7.2 
2.
7 - 
Cyromazine 
2.56 ± 
0.01 1.0 - 250 
0.999
7 
14.
1 -1.3 0.0 
21.
0 
-
5.8 3.7 
2.
6 0.9 
Decoquinate 
8.75 ± 
0.01 0.5 - 150 
0.997
7 
10.
1 -1.7 1.2 
17.
3 
-
5.9 2.5 
2.
1 1.0 
Diaveridine 
4.37 ± 
0.00 0.5 - 150 
0.999
5 7.0 2.6 
-
1.0 
12.
1 
-
1.8 8.6 
2.
5 - 
Diclazuril  
8.32 ± 
0.00 0.1 - 250 
0.998
9 
-
5.9 1.1 
-
20.
1 6.6 
-
5.3 
11.
9 
3.
9 
- 
Dintolmide 
5.52 ± 
0.01 10.0 - 150 
0.998
9 
-
7.2 
-
12.
4 
-
22.
0 3.4 
-
19.
3 0.1 
7.
0 
- 
Ethopabate 
5.61 ± 
0.00 0.1 - 250 
0.998
5 6.4 -1.7 
-
0.7 
14.
8 
-
7.2 1.8 
2.
3 1.8 
Halofuginone 
5.27 ± 
0.00 0.1 - 250 
0.999
3 
14.
9 1.0 
-
2.1 
24.
0 
-
3.9 6.8 
2.
8 2.5 
Imidocarb 
4.03 ± 
0.02 - - 4.9 -2.5 
-
0.9 
10.
8 
-
7.8 2.7 
2.
6 1.4 
Isometamidiu
m 
5.13 ± 
0.08 - - 
-
6.8 2.5 
-
14.
1 1.8 
-
2.8 8.8 
3.
0 
- 
Lasalocid* 
10.03 ± 
0.00 0.1 - 250 
0.995
3 
-
5.0 -1.1 
-
14.
1 1.3 
-
5.8 4.3 
3.
2 
- 
Maduramicin* 
11.33 ± 
0.01 1.0 - 250 
0.998
1 1.1 5.0 
-
16.
2 
20.
9 
-
7.8 
18.
4 
5.
7 
- 
Monensin* 
10.33 ± 
0.01 0.1 - 250 
0.998
7 
-
4.8 3.8 
-
13.
5 3.7 
-
3.5 
11.
5 
3.
8 
- 
Nafamostat 
4.16 ± 
0.02 - - 9.2 -2.2 0.7 
17.
3 
-
9.0 2.4 
2.
9 - 
Narasin* 
11.75 ± 
0.00 0.1 - 250 
0.998
5 
-
5.8 2.1 
-
16.
2 3.1 
-
2.0 8.7 
2.
7 
- 
Nequinate 
7.50 ± 
0.00 0.5 - 150 
0.999
1 8.9 0.6 
-
0.4 
14.
7 
-
3.6 3.3 
1.
8 - 
Nicarbazin 
7.69 ± 
0.00 1.0 - 250 
0.998
8 
11.
1 0.6 
-
1.1 
20.
3 
-
1.7 2.6 
1.
3 1.0 
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Analyte 
tR ±SD 
min 
Calibration 
Range 
(ng L
-1
) 
Linea
rity 
R
2
 
Mean ME 
(%) (n-25) 
ME RANGE (%) RSD 
(n=25) (%) [Low] [High] 
[Lo
w] 
[Hi
gh] 
Mi
n 
Ma
x 
Mi
n 
Ma
x 
No 
IS 
With 
IS 
Nitromide 
5.48 ± 
0.00 20.0 - 250 
0.999
0 
-
5.3 -3.2 
-
16.
7 7.2 
-
9.0 0.7 
2.
5 
- 
Pentamidine 
4.56 ± 
0.02 - - 9.6 0.1 
-
3.8 
19.
7 
-
6.6 6.8 
3.
3 - 
Robenidine 
6.92 ± 
0.02 0.1 - 250 
0.997
3 
13.
0 0.0 1.1 
19.
9 
-
3.4 4.0 
2.
1 1.0 
Salinomycin* 
10.83 ± 
0.00 0.1 - 250 
0.998
5 
-
7.3 -1.8 
-
18.
7 0.1 
-
7.2 5.4 
3.
6 
- 
Semduramicin
* 
9.43 ± 
0.00 1.0 - 250 
0.997
0 
-
4.0 4.2 
-
16.
9 
17.
3 
-
6.1 
13.
0 
5.
2 
- 
Toltrazuril 
8.38 ± 
0.00 20.0 - 250 
0.999
2 6.8 -3.7 
-
1.9 
13.
0 
-
10.
3 2.0 
3.
0 
- 
Toltrazuril 
sulphone 
7.86 ± 
0.00 20.0 - 250 
0.998
8 
-
1.2 3.3 
-
14.
3 
11.
0 
-
6.4 
16.
8 
4.
6 
- 
Toltrazuril 
sulphoxide 
7.19 ± 
0.00 20.0 - 250 
0.998
6 0.7 -0.4 
-
3.7 5.7 
-
8.9 
11.
2 
3.
5 - 
* denotes ionophore compounds,  tR = retention time, SD = standard deviation, R
2 = coefficient of determination, ME = 
matrix effect, RSD = relative standard deviation, IS = internal standard, [Low] = concentration equivalent to calibrant 2 (2.5 
ng L-1 for groups A, B and C and 7.5, 20 and 25 ng L-1 for D, E and F) [High] = concentration equivalent to calibrant 7 (125 ng 
L-1 for standard groups B, C and E and 200 ng L-1 for groups A, D, and F. 
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Table 3. Validation trueness and precision (RSD) under repeatability conditions (WLr) (n = 8) and 
reproducibility conditions(WLR) (n = 29) at four concentration levels for the 26 anticoccidial 
compounds, with their respective limit of detection (LOD) and limit of quantification (LOQ) values 
(ng L-1) 
Analyte 
Validated 
levels 
L1, L2, L3, 
L4 
(ng L-1) 
WLr Trueness (RSDr) (%)
a WLR Trueness (RSDwR) (%)
b 
LOD 
c
 
(ng L-
1) 
LOQ 
d 
(ng L
-
1
) 
L1 L2 L3 L4 L1 L2 L3 L4 
Aklomide 
25, 75, 150, 
200 
102 
(6) 
110 
(5.9) 
98 
(8.2) 
93 
(1.5) 
97 
(9.1) 
102 
(7.6) 
97 
(7.7) 
96 
(6.3) 5 20 
Amprolium 
2.5, 50, 
150, 200 
102 
(4.5) 
109 
(3.5) 
109 
(3.5) 
106 
(3.6) 
105 
(8.6) 
104 
(5.4) 
102 
(6.1) 
99 
(8.8) 0.1 0.5 
ANOT 
20, 50, 100, 
125 
105 
(6.5) 
101 
(3.4) 
98 
(4.1) 
92 
(5.2) 
100 
(7.0) 
99 
(3.3) 
94 
(8.1) 
91 
(7.4) 2.5 10 
Arprinocid 
2.5, 50, 
100, 125 
101 
(3.4) 
99 
(1.9) 
94 
(3.6) 
91 
(1.9) 
104 
(9.6) 
98 
(5.6) 
95 
(6.5) 
93 
(7.4) 0.1 0.5 
Buquinolone 
2.5, 50, 
100, 125 
101 
(1.3) 
90 
(1.8) 
86 
(3.7) 
88 
(2.6) 
101 
(6.8) 
91 
(4.3) 
88 
(5.1) 
88 
(8.0) 0.1 0.5 
Clopidol 
2.5, 50, 
100, 125 
104 
(2.8) 
100 
(1.6) 
96 
(2.4) 
93 
(1.8) 
103 
(8.9) 
98 
(5.3) 
94 
(4.3) 
91 
(4.9) 
0.1 
0.5 
Cyromazine 
7.5, 50, 
150, 200 
100 
(1.2) 
103 
(0.8) 
101 
(0.5) 
100 
(1) 
101 
(2.9) 
101 
(1.4) 
100 
(0.9) 
99 
(1.0) 0.1 1 
Decoquinate 
2.5, 50, 
100, 125 
113 
(1) 
105 
(1.4) 
97 
(1.5) 
93 
(0.9) 
111 
(3.3) 
103 
(3.2) 
97 
(3.0) 
95 
(4.3) 0.1 0.5 
Diaveridine 
2.5, 50, 
100, 125 
100 
(2.1) 
96 
(1.5) 
93 
(3.9) 
92 
(2.8) 
103 
(9.3) 
95 
(5.1) 
91 
(5.7) 
89 
(7.2) 0.15 0.5 
Diclazuril  
2.5, 50, 
150, 200 
100 
(3.8) 
102 
(3.7) 
97 
(1.6) 
98 
(4.7) 
105 
(7.5) 
104 
(5.5) 
100 
(5.6) 
99 
(5.8) 0.02 0.1 
Dinitolmide 
20, 50, 100, 
125 
103 
(3.1) 
105 
(2.1) 
102 
(2.4) 
102 
(2.4) 
102 
(4.4) 
102 
(4.9) 
99 
(8.0) 
99 
(8.6) 2 10 
Ethopabate 
2.5, 50, 
150, 200 
106 
(1.9) 
106 
(2.3) 
100 
(1.5) 
96 
(1.8) 
110 
(9.1) 
105 
(2.0) 
100 
(1.9) 
97 
(2.3) 0.02 0.1 
Halofuginone 
2.5, 50, 
150, 200 
96 (3) 
104 
(2.1) 
103 
(1.9) 
102 
(2.1) 
104 
(8.1) 
102 
(2.7) 
102 
(2.6) 
101 
(2.2) 0.05 0.1 
Lasalocid 
2.5, 50, 
150, 200 
112 
(1.2) 
109 
(1.3) 
94 
(2.6) 
88 (1) 
110 
(3.6) 
107 
(3.8) 
94 
(4.7) 
88 
(4.8) 0.01 0.1 
Maduramicin 
7.5, 50, 
150, 200 
106 
(3.7) 
101 
(5.4) 
94 (8) 
95 
(5.9) 
102 
(6.6) 
106 
(7.1) 
97 
(8.1) 
95 
(9.4) 0.5 1 
Monensin 
2.5, 50, 
150, 200 
102 
(2.4) 
108 
(3.6) 
104 
(3.3) 
102 
(3.3) 
103 
(5.6) 
106 
(7.0) 
100 
(7.5) 
101 
(10.3) 0.005 0.1 
Narasin 
2.5, 50, 
150, 200 
100 
(3) 
100 
(3.3) 
95 
(3.7) 
91 
(2.3) 
101 
(4.7) 
101 
(5.2) 
93 
(3.9) 
91 
(4.5) 0.005 0.1 
Nequinate 
2.5, 50, 
100, 125 
96 
(1.2) 
87 
(1.8) 
86 
(3.4) 
87 
(2.5) 
101 
(3.9) 
90 
(3.8) 
88 
(5.5) 
89 
(7.6) 0.1 0.5 
Nicarbazin 
7.5, 50, 
150, 200 
104 
(0.7) 
104 
(1.8) 
102 
(1.5) 
99 
(1.9) 
103 
(1.7) 
105 
(1.5) 
101 
(1.5) 
100 
(1.5) 0.1 1 
Nitromide 
25, 75, 150, 
200 
103 
(2.3) 
101 
(1.5) 
101 
(1.9) 
99 
(2.3) 
98 
(7.5) 
100 
(3.9) 
99 
(4.9) 
98 
(4.5) 5 20 
Robenidine 
2.5, 50, 
150, 200 
107 
(1.5) 
104 
(0.9) 
103 
(1.3) 
104 
(0.6) 
107 
(2.9) 
101 
(1.9) 
101 
(1.4) 
101 
(1.6) 0.03 0.1 
Salinomycin 
2.5, 50, 
150, 200 
98 
(3.4) 
100 
(3.1) 
96 
(4.6) 
93 
(2.4) 
100 
(5.6) 
99 
(5.6) 
93 
(5.8) 
91 
(6.4) 0.02 0.1 
Semduramicin 
7.5, 50, 
150, 200 
104 
(4.4) 
106 
(7.7) 
93 
(4.7) 
90 
(4.2) 
100 
(5.6) 
99 
(6.2) 
93 
(9.6) 
91 
(8.5) 0.25 1 
Toltrazuril 
25, 75, 150, 
200 
102 
(2.1) 
101 
(1.3) 
102 
(1.7) 
99 (2) 
99 
(4.7) 
99 
(2.6) 
100 
(2.8) 
99 
(3.1) 
4 
20 
Toltrazuril 25, 75, 150, 97 100 100 102 98 99 99 99 10 20 
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Analyte 
Validated 
levels 
L1, L2, L3, 
L4 
(ng L
-1
) 
WLr Trueness (RSDr) (%)
a WLR Trueness (RSDwR) (%)
b 
LOD c 
(ng L-
1) 
LOQ 
d 
(ng L
-
1
) 
L1 L2 L3 L4 L1 L2 L3 L4 
sulphone 200 (2.3) (3) (3.1) (2.4) (3.1) (3.2) (3.1) (3.0) 
Toltrazuril 
sulphoxide 
25, 75, 150, 
200 
97 
(2.1) 
98 
(1.9) 
99 
(2.2) 
98 
(1.5) 
99 
(5.4) 
100 
(2.1) 
99 
(3.5) 
98 
(4.0) 4 20 
a WLr =Within-laboratory repeatability while RSDr = Relative standard deviation under repeatability conditions,
 b 
WLR=Within-laboratory reproducibility, while RSDwR = Relative standard deviation under reproducibility conditions 
c
 LOD = 
Limit of Detection based on S/N = 5, d LOQ = Limit of Quantitation based on S/N = 10.,  L1, L2 ,L3,and L4 refer to each of the 
four 
levels at which the validation was performed, equivalent to calibration points 2, 4, 6 and 7 respectively. 
 
 
Table 4. Summary of the seven anticoccidial compounds, and respective concentration ranges, 
detected during a spatial sampling campaign throughout the Republic of Ireland in 2018 
Anticoccidial Compound 
Detected Concentration  
Range (ng L
-1
)* 
Ionophores  
Lasalocid ≥LOQ – 56 
Monensin ≥LOQ – 386 
Narasin ≥LOQ – 47 
Salinomycin ≥LOQ – 19 
Chemical coccidiostats  
Amprolium ≥LOQ – 50 
Diclzauril ≥LOQ – 66 
Nicarbazin ≥LOQ – 135 
                            * See Table 3 for LOQ of each individual compound 
 
 
         
